ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 49 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $161,000 | -42.5% | 40,000 | -38.5% | 0.00% | -42.9% |
| Q1 2019 | $280,000 | -25.1% | 65,000 | 0.0% | 0.01% | -56.2% |
| Q4 2018 | $374,000 | -60.6% | 65,000 | -7.1% | 0.02% | -36.0% |
| Q3 2018 | $949,000 | -0.1% | 70,000 | -12.5% | 0.02% | +8.7% |
| Q2 2018 | $950,000 | +5.8% | 80,000 | 0.0% | 0.02% | -17.9% |
| Q1 2018 | $898,000 | +34.4% | 80,000 | -20.0% | 0.03% | +64.7% |
| Q4 2017 | $668,000 | -19.2% | 100,000 | -1.0% | 0.02% | -45.2% |
| Q3 2017 | $827,000 | +82.6% | 101,000 | 0.0% | 0.03% | +63.2% |
| Q2 2017 | $453,000 | -25.2% | 101,000 | -8.2% | 0.02% | -20.8% |
| Q1 2017 | $606,000 | +35.9% | 110,000 | 0.0% | 0.02% | +9.1% |
| Q4 2016 | $446,000 | -1.1% | 110,000 | +71.9% | 0.02% | -21.4% |
| Q3 2016 | $451,000 | -15.7% | 64,000 | -2.5% | 0.03% | -31.7% |
| Q2 2016 | $535,000 | -40.2% | 65,610 | -40.4% | 0.04% | +5.1% |
| Q1 2016 | $894,000 | -28.0% | 110,000 | +6.8% | 0.04% | -54.7% |
| Q4 2015 | $1,242,000 | -11.3% | 103,000 | -12.0% | 0.09% | +38.7% |
| Q3 2015 | $1,400,000 | -36.4% | 117,000 | -2.5% | 0.06% | -28.7% |
| Q2 2015 | $2,200,000 | – | 120,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |